may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
. or water. symptoms include fatigue, low appetite, stomach pain, nausea, and jaundice.